Cardior's pioneering miRNA approach in heart failure endorsed by expert opinions in the European Heart Journal
First-ever development of an RNA therapeutic for heart failure Successful translation of unique scientific discovery int…
First-ever development of an RNA therapeutic for heart failure Successful translation of unique scientific discovery int…
Canbex Therapeutics Ltd announced today the appointment of Dr Alberto Lledó as its new Chief Medical Officer (CMO), effe…
The Hospital de la Santa Creu i Sant Pau and Royal Philips Electronics (NYSE: PHG, AEX: PHI) today signed a 10-year agre…